London close: Stocks fall as US inflation tops expectations
13th Feb 2024 16:21
(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.
Read moreLondon close: Stocks fall as US inflation tops expectations
13th Feb 2024 16:21
(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.
Read moreCiti ups recommendation on GSK to 'buy'
13th Feb 2024 09:45
(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.
Read moreLondon close: Stocks finish higher after very quiet Monday
12th Feb 2024 17:11
(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.
Read moreGSK gets FDA fast track for chronic hepatitis B treatment
12th Feb 2024 07:21
(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).
Read moreGSK reports positive myeloma trial results, progresses vaccine applications
6th Feb 2024 07:23
(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.
Read moreGSK settles Zantac case in California without admitting liability
1st Feb 2024 09:11
(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.
Read moreLondon close: Stocks mixed ahead of US Fed, BoE decisions
31st Jan 2024 15:49
(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.
Read moreGSK gets EU approval to sell blood cancer treatment Omijara
29th Jan 2024 07:07
(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.
Read moreCiti hikes target price for GSK but stays 'neutral'
26th Jan 2024 10:47
(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.
Read moreGSK raises £978m through Haleon share sale
17th Jan 2024 08:05
(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.
Read moreUBS downgrades AstraZeneca to 'sell'
16th Jan 2024 08:15
(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.
Read moreZantac fallout unfairly weighing on GSK, says Shore Capital
15th Jan 2024 08:42
(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.
Read moreGSK's Nucala gets fresh approval in China
10th Jan 2024 07:22
(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.
Read moreLondon close: Stocks finish red after choppy session
9th Jan 2024 16:22
(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.
Read more